Evaluating diagnosis and treatment of oral and esophageal candidiasis in Ugandan AIDS patients.

Ravera, M.; Reggiori, A.; Agliata, A. M.; Rocco, R. P.

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Evaluating diagnosis and treatment of oral and esophageal candidiasis in Ugandan AIDS patients.

Published Date:

1999 Mar-Apr

Source:

Emerg Infect Dis. 5(2):274-277.

[PDF-83.19 KB]

Details:

Personal Authors:

Ravera, M. ; Reggiori, A. ; Agliata, A. M. ; Rocco, R. P. ;

Keywords:

[+]

Description:

A randomized cross-over clinical and endoscopic evaluation of 85 Ugandan patients showed that esophageal candidiasis in AIDS patients with oral candidiasis could be managed without endoscopy and biopsies. Oral lesions, especially when accompanied by esophageal symptoms, were sufficient for diagnosis. Miconazole was more effective than nystatin in treating esophageal candidiasis and could be a valid alternative to more expensive azolic drugs in developing countries.

Document Type:

Journal Article

Collection(s):

Emerging Infectious Diseases

Main Document Checksum:

[+]

Supporting Files:

	10221882.nxml	text/plain
	license.txt	text/plain

No Related Documents.

You May Also Like:

Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents : recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America

Corporate Author:

Centers for Disease Control and Prevention (U.S.). National Institutes of Health (U.S.). HIV Medicine Association.. United States. AIDSinfo. Opportunistic Infections Working Group..

Published:

October 21, 2015; last reviewed May 7, 2013

Description:

Sections updated frequently: see "What's New in the Guidelines" at https://aidsinfo.nih.gov/guidelines/html/4/adult-and-adolescent-oi-prevention-and-treatment-guidelines/392/whats-new : The Guidelines for the Prevention and Treatment of Opportunistic...

Status:

current

File Type:

[PDF - 5.97 MB]
Guidelines for the prevention and treatment of opportunistic infections among HIV-exposed and HIV-infected children; recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics

Personal Author:

Danner, Susie P.; Dominguez, Kenneth L.; Mofenson, Lynne M.; Nesheim, Steven R.;

Corporate Author:

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). American Academy of Pediatrics. Centers for Disease Control and Prevention (U.S.). HIV Medicine Association. National Institutes of Health (U.S.). Pediatric Infectious Diseases Society.

Published:

September 4, 2009

Source:

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 2009; 58(RR-11):1-166.

Series:

Morbidity and mortality weekly report. Recommendations and reports ; v. 58, no. RR-11
MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 58, no. RR-11

Description:

This report updates and combines into one document earlier versions of guidelines for preventing and treating opportunistic infections (OIs) among HIV-exposed and HIV-infected children, last published in 2002 and 2004, respectively. These guidelines ...

Status:

superseded

File Type:

[PDF - 2.08 MB]
Treating opportunistic infections among HIV-exposed and infected children; recommendations from the Ceters for Disease Control and Prevention, the National Institutes of Health, and the Infectious Diseases Society of America

Personal Author:

Mofenson, Lynne M.

Corporate Author:

Centers for Disease Control and Prevention (U.S.). Infectious Diseases Society of America. National Center for HIV, STD and TB Prevention (U.S.). National Institutes of Health (U.S.).

Published:

December 3, 2004

Series:

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 53, no. RR-14
Clinical infectious diseases ; v. 40, suppl. 1

Description:

"In 2001, CDC, the National Institutes of Health, and the Infectious Diseases Society of America convened a working group to develop guidelines for therapy of human immunodeficiency virus (HIV)-associated opportunistic infections to serve as a compan...

File Type:

[PDF - 742.29 KB]
Guidelines for prevention and treatment opportunistic infections in HIV-infected adults and adolescents; recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America

Personal Author:

Benson, Constance A.; Brooks, John T.; Holmes, King K.; Kaplan, Jonathan E.; Masur, Henry; Pau, Alice;

Corporate Author:

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Centers for Disease Control and Prevention (U.S.). HIV Medicine Association. Infectious Diseases Society of America. National Institutes of Health (U.S.).

Published:

April 10, 2009

Source:

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 2009; 58(RR-4):1-207; quiz CE1-4.

Series:

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 58, RR-4

Description:

"This report updates and combines earlier versions of guidelines for the prevention and treatment of opportunistic infections (OIs) in HIV-infected adults (i.e., persons aged >18 years) and adolescents (i.e., persons aged 13--17 years), last publishe...
18 years) and adolescents (i.e., persons aged 13--17 years), last publishe...">

Status:

superseded

File Type:

[PDF - 2.33 MB]
Emerging disease issues and fungal pathogens associated with HIV infection.

Personal Author:

Ampel, N. M.

Published:

1996 Apr-Jun

Source:

Emerg Infect Dis. 2(2):109-116.

Description:

Fungal diseases are increasing among patients infected with human immunodeficiency virus (HIV) type 1. Infections due to Candida and Cryptococcus are the most common. Although mucocutaneous candidiasis can be treated with oral antifungal agents, incr...

File Type:

[PDF - 60.89 KB]